Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAT therapy for sepsis in acute NSTI
NCT05157360Phase 2Terminated
- Sponsor
- Ascension Via Christi
- Start
- Sep 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone, ascorbic acid, thiamine in sepsis, necrotizing soft tissue infection (NSTI), sponsored by Ascension Via Christi. Started Sep 2021; status: terminated.
02
Drugs
hydrocortisoneascorbic acidthiamine
03
Conditions
sepsisnecrotizing soft tissue infection (NSTI)
Beyond the preview
Go deeper on NCT05157360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157360.